CYP11A1 and myopia: The major product of novel cytochrome P450scc (CYP11A1)-initiated pathway of vitamin D3 metabolism, 20-hydroxyvitamin D3 (20(OH)D3), and its metabolites may have anti-proliferative, pro-differentiation, and anti-inflammatory effects, which could prevent myopia [54–56].